The Effect of tDCS on Schizophrenia With Negative Symptoms
NCT: NCT03729791 · WITHDRAWN
NCT IDNCT03729791
StatusWITHDRAWN
Start Date2019-12-01
Completion2020-12-01
Brief Summary
The investigators conducted a randomized controlled trial to reveal the effect of tDCS on negative symptoms in patients with schizophrenia and its underlying mechanism using the neuroimaging and electrophysiology.
Frequently Asked Questions
What is The Effect of tDCS on Schizophrenia With Negative Symptoms?
The Effect of tDCS on Schizophrenia With Negative Symptoms is a clinical trial registered under NCT03729791. Current status: WITHDRAWN.
What is the status of NCT03729791?
The current status of NCT03729791 (The Effect of tDCS on Schizophrenia With Negative Symptoms) is: WITHDRAWN.
When did The Effect of tDCS on Schizophrenia With Negative Symptoms start?
The Effect of tDCS on Schizophrenia With Negative Symptoms started on 2019-12-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.